We are happy to share a positive information to all who support Ukraine and our clinical trials industry. Please find below a report from the State Expert Center of the Ministry of Health of Ukraine regarding the state of clinical trials in 2023, published on 29th January 2024.
In 2023, the State Expert Center received 41 statements from sponsors regarding the start of clinical trials in Ukraine. The main therapeutic areas where clinical trials were carried out were oncology, allergology, neurology, cardiology, and dermatology. At the beginning of the year, 400 clinical trials were registered in Ukraine, out of which 309 started. This represents a 64% increase in the number of clinical trials started in 2023. The number of local ethics commissions also increased from 308 in 2022 to 390 in 2023.
The number of clinical trials in Ukraine launched in 2023 increased by 64%!
In 2023, the Expert Center conducted 40 audits (39 sites, 1 CRO office), which is similar to the number of audits conducted in 2022 (45), the year before the russian aggression. Get the full report of the clinical trials in Ukraine Expert Center for 2023.
MICS Ukraine is operating on a full scale
Medicover Integrated Clinical Services business unit in Ukraine operates across the country in a full scale and supports 62 clinical trials projects. MICS Ukraine is presented by actively functioning 6 labs and 320+ blood-collection offices. Moreover, all global courier companies resumed their logistics support in the country. I hope this information and current data help our partners and decision-makers to find possibilities for returning to Ukraine! – says Oleksii Gaidamak, Business Development Director, Medicover Integrated Clinical Services Ukraine.
Find out more about our Central Laboratory Services.
FAQ about clinical trials in Ukraine
1. Are clinical trials currently active in Ukraine despite the war?
Yes. According to official reports, Ukraine continues to conduct clinical trials nationwide, supported by functioning laboratories, investigator sites, and resumed courier logistics. Activity levels have recovered significantly compared to early 2022.
2. Which therapeutic areas are most commonly studied in Ukraine right now?
The leading therapeutic areas include oncology, allergology, neurology, cardiology, and dermatology — reflecting global research trends and robust patient recruitment potential.
3. Has clinical trial activity increased in 2023?
Yes. The number of launched clinical trials in Ukraine increased by 64% in 2023 compared to previous years, showing strong resilience of the research ecosystem.
4. How has the number of ethics committees changed?
Local ethics commissions expanded from 308 in 2022 to 390 in 2023, strengthening regulatory oversight and the capacity to review new studies.
5. Is international logistics operational for sample movement?
Yes. All leading global courier companies have fully resumed operations, which is essential for central laboratory workflows and biological sample transport.
6. Can sponsors safely return their studies to Ukraine?
Current data suggests yes. Operational infrastructure, audit capacity, and site performance remain stable. Many sponsors are returning, supported by local expertise, regulatory continuity, and reliable laboratory networks.
References
Clinical Trials in Ukraine: On the Path to Recovery, European Business Association (EBA), Accessed: 21 October 2025.
Protecting Clinical Research, Researchers, and Participants in Ukraine, Drug Information Association (DIA), Accessed: 21 October 2025.
